Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification.
- DOI
- 10.1002/2056-4538.70030
- Published
- 2025 Sep
- Container
- The journal of pathology. Clinical research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/2056-4538.70030,
title = {Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification.},
author = {Odeh S and Samarska I and Matoso A and Baldewijns MM and Hulsbergen-van de Kaa CA and Zur Hausen A and van Engeland M and Schouten LJ and Smits KM},
year = {2025},
journal = {The journal of pathology. Clinical research},
doi = {10.1002/2056-4538.70030},
url = {https://doi.org/10.1002/2056-4538.70030}
}RIS
TY - JOUR TI - Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification. AU - Odeh S AU - Samarska I AU - Matoso A AU - Baldewijns MM AU - Hulsbergen-van de Kaa CA AU - Zur Hausen A AU - van Engeland M AU - Schouten LJ AU - Smits KM PY - 2025 JO - The journal of pathology. Clinical research DO - 10.1002/2056-4538.70030 UR - https://doi.org/10.1002/2056-4538.70030 ER -
APA
S, O., I, S., A, M., MM, B., CA, H. D. K., A, Z. H., M, V. E., LJ, S., & KM, S. (2025). Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers: an update after ISUP/WHO 2022 classification.. The journal of pathology. Clinical research. https://doi.org/10.1002/2056-4538.70030
Source records
- pubmed · retrieved 2026-09-25T22:40:23.987Z